| Birrenbach, Iris (bp independent research 200504) |
n. a. |
bp independent research GmbH |
Germany |
| Birsner, Ulrich (GeneScan Europe 200007 CEO) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
Germany |
| Bischof, Matthias (Austria (govt) 201107 Head of Communications at aws) |
Public Relations Manager / Investor Relations Manager |
Austria (govt) |
Austria |
| Bischofberger, Norbert (Gilead Sciences 200903 EVP R&D CSO) |
Board member, executive |
Gilead Sciences (Group) |
United States (USA) |
| Bischoff, Klaus (Merck (D) 200802 Head Performance & Life Science Chemicals division) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Bischoff, Ralf (Pepperprint GmbH 201305 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pepperprint GmbH |
Germany |
| Biselli, Scarlett (Eurofins 201306 Eurofins WEJ Contaminants GmbH) |
n. a. |
Eurofins (Group) |
Germany |
| Bishop, Hans E. (Juno Therapeutics 201601 CEO + Co-Founder before Dendreon + Bayer + GW + SKB) |
Chief Executive Officer (CEO) |
Celgene (Group) |
United States (USA) |
| Bishop, John L. (Cepheid 200507 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Biskup, Dirk (CeGAT GmbH 200907– Managing Director + founder) |
Managing Director |
CeGaT (Group) |
Germany |
| Biskup, Peer (BayPAT 200807– Managing Director before Innowi GmbH) |
Managing Director |
Universität Bayern e. V. (Uni Bayern e. V.) |
Germany |
| Biskup, Saskia (CeGAT GmbH 200907– Managing Director + founder) |
Managing Director |
CeGaT (Group) |
Germany |
| Bissinger, Michael (Volks- und Raiffeisenbanken 201012 DZ Bank Analyst Healthcare) |
Analyst (Financial / Industry) |
Volks- und Raiffeisenbanken (DE) (Group) |
Germany |
| Bitter-Suermann, Dieter (Medizinische Hochschule Hannover 200610 President) |
n. a. |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
| Bittner, Martin-Immanuel (Trinitiy College Oxford + Arctoris Ltd 201901) |
n. a. |
University of Oxford |
United Kingdom (GB) |
| Bitzer, Michael (Univ Tübingen 201009 Professor Univ Hospital Tübingen) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Bizzari, Jean-Pierre (Nordic Nanovector 201605– Board Memeber before Celgene + Sanofi-Aventis) |
Board member |
Nordic Nanovector (Group) |
Norway |
| Bjerke, Torbjørn (Karolinska Institutet 201306 CEO of Karolinska Development before Orexo CEO before Biolipox CEO) |
Chief Executive Officer (CEO) |
Karolinska Development AB (Nasdaq Stockholm: KDEV) |
Sweden |
| Björklund, Håkan (Lundbeck 201310 Board Chairman before Nycomed 1999–2011 CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Switzerland |
| Blackman, Lorraine (Rentschler 201911– Head Human Resources at Rentschler Biopharma Inc) |
Human Resources Manager |
Rentschler (Group) |
United States (USA) |
| Blackwell, Chris (Vectura 200504 CEO) |
Chief Executive Officer (CEO) |
Vectura (Group) |
United Kingdom (GB) |
| Blain, David (Reinnervate 200709– CFO) |
Chief Financial Officer (CFO) |
ReproCell (Group) |
United Kingdom (GB) |
| Blair, Rainer M. (Danaher 201701 EVP Life Sciences before Head Life Sciences + AB Sciex + Videojet + MAPEI + BASF) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Blanarik, Ivan (Boehringer 201707 SVP + Head Therapeutic Area Biosimilars) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Blank, Michael (Verve Capital Partners 201807 Investment Manager) |
Investment Manager |
Verve Capital Partners AG (investiere.ch) |
Switzerland |
| Blank, Wolfgang (BioCon Valley 201103 Managing Director) |
Managing Director |
BioCon Valley GmbH |
Germany |
| Blanke, Gernot (Blanke Meier Evers + Kompass Private Equity) |
n. a. |
Blanke Meier Evers |
Germany |
| Blankenburg, Axel (Euroimmun 201207 CFO) |
Chief Financial Officer (CFO) |
PerkinElmer (Group) |
Germany |
| Blasco, María (CNIO 201312 Director) |
President/Director/Head Business Group/Unit/Division |
CNIO (Centro Nacional de Investigaciones Oncológicas) |
Spain (España) |
| Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries) |
Chief Financial Officer (CFO) |
Basilea (Group) |
Switzerland |
| Blaukat, Andree (Merck (DE) 201312 Head Translational Innovation Platform Oncology at Merck Serono) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Blavier, André (Interactive Biosoftware 201211 CEO + Founder) |
Chief Executive Officer (CEO) |
Sophia Genetics (Group) |
France |
| Bléhaut, Jean (Novasep 201509 Chief Innovation Officer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Novasep (Group) |
France |
| Bleiholder, Christian (Florida State Univ 201606 Professor at Dept of Chemistry + Biochemistry) |
Professor |
Florida State University (FSU) |
United States (USA) |
| Bleile, Bernd (Curetis 201602– in-house Legal Counsel) |
Legal Manager |
Curetis (Group) |
Germany |
| Blind, Michael (NascaCell 200809 CEO) |
Chief Executive Officer (CEO) |
NascaCell (Group) |
Germany |
| Block, Christoph (Signalomics 200604–201307 CEO LEFT 7/13) |
Chief Executive Officer (CEO) |
Signalomics GmbH |
Germany |
| Blome, James A. (Jim) (Cellectis 201810– CEO of Calyxt Inc before Bayer CropScience LP + Valent + Agrliance) |
Chief Executive Officer (CEO) |
Cellectis (Group) |
United States (USA) |
| Bloom, Kenneth (General Electric 201402 CMO of Clarient Diagnostics Services Inc) |
Chief Medical Officer (CMO) |
General Electric (Group) |
United States (USA) |
| Bloomfield, Mark (Polyplus-transfection 201004– CEO before ABI + Thermo Electron + Agilent + HP) |
Chief Executive Officer (CEO) |
Polyplus-transfection (Group) |
France |
| Bluestein, Scott (Hercules Technology 201812 Chief Investment Officer at Hercules Capital) |
Investment Manager |
Hercules Technology Growth Capital Inc. (Nasdaq: HTGC) |
United States (USA) |
| Blumenthal, Ralf (Qiagen 200610 Associate Director BusDev) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Blunier, Heinz (Febit 200901– COO before Inventa + Tegimenta + Boehringer Mannheim) |
Chief Operating Officer (COO) |
febit (Group) |
Germany |
| Blöcker, Helmut |
n. a. |
Humangenomprojekt (DE) |
Germany |
| Blöndal, Arni (Brunnur Ventures 201810) |
Investment Manager |
Brunnur Ventures |
Iceland |
| Bobbert, Cornelius |
n. a. |
Kuhnen & Wacker Patent- und Rechtsanwaltsbüro |
Germany |
| Bocci, Marco (Selexis 201311– Director European Sales + Business Development before Quintiles) |
Sales Manager / Marketing Manager |
JSR Corporation (Group) |
Switzerland |
| Boch, Gary (CEVEC Pharmaceuticals 201011 VP BusDev + Head US Business) |
Chief Commercial Officer (CCO) |
Cevec (Group) |
United States (USA) |
| Bochtler, Hans Joachim (MediGene 200809– Head RnD before Fresenius Biotech) |
Research & Development Manager |
Medigene (Group) |
Germany |
| Bock, Holger (Ugichem 201108 Managing Director CEO + founder) |
Managing Director |
Ugichem Gesellschaft für organische Chemie mbH |
Austria |
| Bode, Jörg (Niedersachsen (govt) 200912 Minister of Economic Affairs, Labour and Transport) |
Minister |
Niedersachsen (govt region) |
Germany |
| Bode, Tim (Business Angel) |
n. a. |
PERSON |
|
| Bodenmiller, Bernd (Univ Zurich 201710 Assistant Professor) |
Professor |
University of Zurich (UZH) |
Switzerland |
| Bodiselitsch, Bernd (Imprint Analytics 201812 Managing Director) |
Managing Director |
Imprint Analytics GmbH |
Austria |
| Bodson, Bertrand (Novartis 201801– Chief Digital Officer before Sainsbury’s Argos + EMI + Amazon + Boston Consulting) |
Chief Information Officer (CIO) / Chief Digital Officer |
Novartis (Group) |
Switzerland |
| Boehler, Michael (BioNTech 201905 Head of Global External Communications) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Germany |
| Boehm, Dr. (Heidelberg Pharma 200610 Chief Development Officer) |
Research & Development Manager |
Heidelberg Pharma (Group) |
Germany |
| Boehm, Rainer (Cellectis 201706– Board Member before 29y at Novartis) |
Board member, non-executive |
Cellectis (Group) |
France |
| Boehnlein, Ernst (NascaCell 200708 CEO) |
Chief Executive Officer (CEO) |
NascaCell (Group) |
Germany |
| Boehringer, Christian (Boehringer 201207 Chairman of Shareholders’ Committee) |
Board member, non-executive |
Boehringer Ingelheim (Group) |
Germany |
| Boehringer, Christoph (Mediatum 2001– Managing Director + CD-Venture 2003– Managing Director + co-owner Boehringer) |
Managing Director |
Mediatum (Group) |
Germany |
| Boehringer, Mathias Albert (Boehringer 200809 Gesellschafterausschuss) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Boesen, Jan (IBL International GmbH 201407 Managing Director) |
Managing Director |
Tecan (Group) |
Germany |
| Boesl-von Grafenstein, Ulrich (TU München 201007 Professor Physical Chemistry) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Bogenstätter, Michael (Germany (govt) 201707 German Accelerator Life Sciences) |
n. a. |
Germany (govt) |
United States (USA) |
| Bogsch, Erik (Gedeon Richter 19982– CEO joined 1970) |
Chief Executive Officer (CEO) |
Gedeon Richter (Group) |
Hungary |
| Bogsch, Erik [2] (Gedeon Richter 201405 Deputy Director Biotechnology) |
President/Director/Head Business Group/Unit/Division |
Gedeon Richter (Group) |
Hungary |
| Bohen, Sean (AstraZeneca 201509– EVP Global Medicines Developent + CMO before Genentech + Stanford Univ) |
Chief Medical Officer (CMO) |
AstraZeneca (Group) |
United Kingdom (GB) |
| Bohlen, Heribert (Axiogenesis 201603 CEO) |
Chief Executive Officer (CEO) |
Evotec (Group) |
Germany |
| Bohm, Katarina (Promega 201411 Head of Marketing at Promega GmbH) |
Sales Manager / Marketing Manager |
Promega (Group) |
Germany |
| Bohmann, Armin (Bohmann & Loosen 200809) |
n. a. |
Bohmann & Loosen (Munich) |
Germany |
| Bohn, Thomas |
n. a. |
febit (Group) |
Germany |
| Bois, Sabine (SAW Instruments 2010– Managing Director Head Finance + co-founder) |
Managing Director |
NanoTemper (Group) |
Germany |
| Boissel, Stéphane (TxCell 201504– CEO before Genclis + Transgene + Innate Pharma + Lazard) |
Chief Executive Officer (CEO) |
TxCell S.A. (Euronext Paris: TXCL) |
France |
| Boles, Eckhard (Univ Frankfurt 201404 Professor + Head of Institute of Physiology + Genetics of Lower Eukaryotes) |
Professor |
University of Frankfurt (Goethe-Universität) |
Germany |
| Bolliger, Luca (Novimmune 201012 Director Business Development + Communication) |
Business Development Manager / Strategy Manager |
Novimmune S.A. |
Switzerland |
| Bollineni, Ravi Chand (Univ Leipzig 201106 Workin Group Bioanalytics) |
Researcher (university / research institute) |
University of Leipzig |
Germany |
| Bollmann, Magdolna (IMoGen GmbH 201104 Managing Director) |
Managing Director |
IMogen Institut für Molekularpathologie und Gendiagnostik GmbH |
Germany |
| Bolzon, Bradley (Versant Ventures 200701 Managing Director) |
Managing Director |
Versant Ventures |
United States (USA) |
| Bond, Colin (Vifor Pharma 201707 CFO before Evotec 201008–201606 CFO LEFT 6/16) |
Chief Financial Officer (CFO) |
Vifor Pharma (Group) |
Switzerland |
| Bonde, Martin (Vaccibody 201508– CEO before EpiTherapeutics ApS + Aros Pharma ApS + Natimmune AS + Combio AS) |
Chief Executive Officer (CEO) |
Vaccibody AS |
Norway |
| Bonenberger, Michael (MCH Group 201807 Exhibition Director ILMAC) |
Event Manager / Conference Manager |
MCH Group AG |
Switzerland |
| Bongaerts, Sabine (Bayer 201605 Head of Drug Discovery Animal Health) |
President/Director/Head Business Group/Unit/Division |
Elanco (Group) |
Germany |
| Bonham-Carter, John (Refine Technology 201201 VP Sales + Business Development) |
Sales Manager / Marketing Manager |
Refine Technology LLC |
United States (USA) |
| Bonifacio, Ezio (TU Dresden 201712 Director of CRTD) |
Professor |
Technical University Dresden (TU Dresden) |
Germany |
| Bonin, Michael (IMGM Laboratories GmbH 201408– Managing Director before Univ Tübingen Director of MFTServices) |
Managing Director |
IMGM Laboratories GmbH |
Germany |
| Bonn, Günther (Univ Innsbruck 201211 Professor + Scientific Director at ADSI) |
Professor |
University of Innsbruck |
Austria |
| Bonnet, Lucille (High-Tech Gründerfonds 201604 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Bonny, Christophe (Enterome 201609– CSO before Bicycle Therapeutics + Xigen + Univ Hospital Lausanne) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Enterome S.A. |
France |
| Bonvicini, Paola (Helsinn 201705 Group Head of Communication) |
Public Relations Manager / Investor Relations Manager |
Helsinn (Group) |
Switzerland |
| Boomgaarden, Wolfgang (PharmaInformatic 200509 founder) |
n. a. |
PharmaInformatic Boomgaarden |
Germany |
| Boorsma, Marco (Forbion Capital Partners 201302) |
Partner (venture partner) |
Forbion Capital Partners (NL) |
Netherlands |
| Boos, Andreas (Curetis 200812– Managing Director) |
Managing Director |
Curetis (Group) |
Germany |
| Boos, Erwin (Schroders 201709 Schroder Adveq) |
Investment Manager |
Schroders (Group) |
Switzerland |
| Boosfeld, Jochen (Bruker 200809 Bruker Daltonik GmbH) |
Sales Manager / Marketing Manager |
Bruker Corporation (Group) |
Germany |
| Boot, Harry (Lonza 201103–201205 COO Life Science Ingredients sector before Bluestar/Blackstone + GE) |
Chief Operating Officer (COO) |
Lonza Group (Group) |
Switzerland |
| Booth, Bruce (Atlas Venture 201306 Partner) |
Partner (venture partner) |
Atlas Venture (Group) |
United States (USA) |
| Booth, Mark (Probiodrug 201603–201608 CBO LEFT 8/16 before Orexigen + Takeda + Immunex + Abbott) |
Chief Business Officer (CBO) |
Vivoryon (Group) |
Germany |
| Booth, Mike (Algeta 201110– SVP Communications + Corporate Affairs before Head of Trout International before UBS London) |
public relations / investor relations |
Bayer (Group) |
Norway |
| Borchers, Christoph (Univ Victoria 200911 Facility Director UVic Proteomics Centre + MRM Proteomics 201008– CSO) |
n. a. |
University of Victoria (UVic) |
Canada |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lse-life-sciences-europe-com.jpg)
1 2 3 ... 5 6 7 ... 68 69 70 
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
